GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TSI Group Co 603262.SS · CNY

Consumer Staples · Shanghai · 🇨🇳 China

Compare

15.28

+0.59%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About TSI Group Co

Its shares trade on Shanghai under the ticker 603262.SS. It has been listed since 23 July 2025. In the fiscal year to 31 December 2024, it reported revenue of CN¥1.00bn and net income of CN¥174.4m. At that date it held total assets of CN¥1.19bn and shareholders' equity of CN¥937.2m.

TSI Group Co., Ltd. engages in the research and development, and manufacture of dietary nutritional supplements. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2025-07-23. The firm's main products include nutritional raw materials such as β-hydroxy β-methyl butyrate (HMB), glucosamine, chondroitin sulfate, and preparations such as tablets and hard capsules. The firm owns the myHMB and GlucosaGreen brands. The firm conducts business in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
23 Jul 2025
Employees
687

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • TSI Group Co Ltd employs 687 full-time employees in Shanghai, China.
  • TSI Group Co Ltd manufactures HMB, glucosamine, and chondroitin sulfate products.
  • TSI Group Co Ltd owns the myHMB and GlucosaGreen brands for nutritional supplements.

Weaknesses

  • TSI Group Co Ltd has a limited product range focusing on dietary supplements only.
  • TSI Group Co Ltd's business is primarily domestic with limited overseas market presence.
  • TSI Group Co Ltd's IPO occurred on 23 July 2025, indicating recent market entry.

Opportunities

  • TSI Group Co Ltd can expand its product line to include more dietary supplement categories.
  • TSI Group Co Ltd can target overseas markets for growth beyond domestic sales.
  • TSI Group Co Ltd can leverage its brands myHMB and GlucosaGreen for international expansion.

Threats

  • TSI Group Co Ltd faces competition from established dietary supplement manufacturers in China.
  • TSI Group Co Ltd must navigate regulatory challenges in the Chinese dietary supplement market.
  • TSI Group Co Ltd's recent IPO may lead to increased scrutiny from investors and regulators.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.